ifosfamide has been researched along with Urinary Retention in 1 studies
Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).
Excerpt | Relevance | Reference |
---|---|---|
" We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC." | 7.78 | Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide. ( Hayashi, T; Matsuoka, K; Nishihara, K; Tomiyasu, K; Uemura, K, 2012) |
" We report a patient who improved following intra-arterial infusion of cisplatin (CDDP) and ifosfamide (IFM) to treat urinary retention caused by locally recurring HRPC." | 3.78 | Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide. ( Hayashi, T; Matsuoka, K; Nishihara, K; Tomiyasu, K; Uemura, K, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Uemura, K | 1 |
Nishihara, K | 1 |
Hayashi, T | 1 |
Tomiyasu, K | 1 |
Matsuoka, K | 1 |
1 other study available for ifosfamide and Urinary Retention
Article | Year |
---|---|
Improvement in urinary retention due to recurrent anastomotic prostate cancer treated with various therapies by intra-arterial infusion of cisplatin and ifosfamide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Humans; Ifosfamide; Infusions, Intra-Arte | 2012 |